Suppr超能文献

中国动脉粥样硬化性心血管病风险评估系统(China-PAR)中10年动脉粥样硬化性心血管病风险方程对新发下肢外周动脉疾病的预测价值

Predictive value of 10-year atherosclerotic cardiovascular disease risk equations from the China-PAR for new-onset lower extremity peripheral artery disease.

作者信息

He Pengkang, Fan Fangfang, Chen Chuyun, Liu Bo, Jia Jia, Sun Pengfei, Li Jianping, Zhou Jing, Zhang Yan

机构信息

Department of Cardiology, Peking University First Hospital, Institute of Cardiovascular Disease, Peking University First Hospital, Beijing, China.

出版信息

Front Cardiovasc Med. 2022 Oct 4;9:933054. doi: 10.3389/fcvm.2022.933054. eCollection 2022.

Abstract

Lower extremity peripheral artery disease (LEPAD) is a common and serious health-threatening disease. The aim of this study was to evaluate the predictive value of 10-year atherosclerotic cardiovascular disease (ASCVD) risk equations from the Prediction for ASCVD Risk in China (China-PAR) project for incident LEPAD after 6.75 ± 0.13 years of follow-up. A total of 3,595 Chinese participants without baseline ASCVD or LEPAD from a community-based cohort were enrolled in our study. The mean (interquartile range) baseline 10-year China-PAR ASCVD risk was 4.35% (2.24-8.44%), and the incidence of new-onset LEPAD during 6.75 ± 0.13 years was 4.23%. In univariable logistic regression analysis, 10-year China-PAR ASCVD risk was significantly associated with LEPAD incidence (odds ratio [OR] for each 1% increase in the risk score = 1.06, 95% confidence interval [CI]: 1.03-1.08, < 0.001). After adjusting confounders, the relationship remained significant (OR: 1.09, 95% CI: 1.05-1.1. < 0.001). Participants with the highest risk (≥10%) had significantly increased risk compared to those with the lowest risk (<5%) (OR = 2.65, 95% CI: 1.15-6.07, = 0.022). Further interaction analyses showed no evidence of heterogeneity according to sex, age, body mass index (BMI), smoking, drinking, hypertension, diabetes mellitus, dyslipidemia, renal function, waist circumference, and family history. In conclusion, 10-year China-PAR ASCVD risk independently predicted the risk of new-onset LEPAD in a Chinese community-based population, indicating the importance of polyvascular diseases (PVDs) and the intrinsic interactions of its components.

摘要

下肢外周动脉疾病(LEPAD)是一种常见且严重威胁健康的疾病。本研究旨在评估中国动脉粥样硬化性心血管疾病(ASCVD)风险预测(China-PAR)项目中的10年ASCVD风险方程对随访6.75±0.13年后新发LEPAD的预测价值。我们的研究纳入了来自一个社区队列的3595名无基线ASCVD或LEPAD的中国参与者。基线时10年China-PAR ASCVD风险的平均值(四分位间距)为4.35%(2.24 - 8.44%),6.75±0.13年期间新发LEPAD的发生率为4.23%。在单变量逻辑回归分析中,10年China-PAR ASCVD风险与LEPAD发生率显著相关(风险评分每增加1%的比值比[OR]=1.06,95%置信区间[CI]:1.03 - 1.08,P<0.001)。在调整混杂因素后,这种关系仍然显著(OR:1.09,95%CI:1.05 - 1.1,P<0.001)。与风险最低(<5%)的参与者相比,风险最高(≥10%)的参与者风险显著增加(OR = 2.65,95%CI:1.15 - 6.07,P = 0.022)。进一步的交互分析显示,根据性别、年龄、体重指数(BMI)、吸烟、饮酒、高血压、糖尿病、血脂异常、肾功能、腰围和家族史,没有异质性证据。总之,10年China-PAR ASCVD风险独立预测了中国社区人群中新发LEPAD的风险,表明了多血管疾病(PVDs)及其组成部分的内在相互作用的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9635/9577020/b84a7b33f025/fcvm-09-933054-g001.jpg

相似文献

2
Prediction of 10-year atherosclerotic cardiovascular disease risk among community residents in Shanghai, China - a comparative analysis of risk algorithms.
Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2058-2067. doi: 10.1016/j.numecd.2021.04.009. Epub 2021 Apr 20.
3
Risk stratification of atherosclerotic cardiovascular disease in Chinese adults.
Chronic Dis Transl Med. 2016 Oct 21;2(2):102-109. doi: 10.1016/j.cdtm.2016.10.001. eCollection 2016 Jun.
6
Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China: Results From the CHERRY Study.
JACC Asia. 2022 Jan 4;2(1):33-43. doi: 10.1016/j.jacasi.2021.10.007. eCollection 2022 Feb.
8
Angiopoietin-related growth factor is independently associated with lower extremity peripheral arterial disease.
J Diabetes Complications. 2017 Feb;31(2):433-438. doi: 10.1016/j.jdiacomp.2016.10.019. Epub 2016 Oct 27.
10
Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project.
Sci China Life Sci. 2018 May;61(5):504-514. doi: 10.1007/s11427-018-9281-6. Epub 2018 Mar 19.

引用本文的文献

本文引用的文献

2
Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy.
Atherosclerosis. 2020 Dec;315:10-17. doi: 10.1016/j.atherosclerosis.2020.11.001. Epub 2020 Nov 6.
5
Polyvascular Disease: Reappraisal of the Current Clinical Landscape.
Circ Cardiovasc Interv. 2019 Dec;12(12):e007385. doi: 10.1161/CIRCINTERVENTIONS.119.007385. Epub 2019 Dec 13.
6
Valvular calcification and risk of peripheral artery disease: the Multi-Ethnic Study of Atherosclerosis (MESA).
Eur Heart J Cardiovasc Imaging. 2020 Oct 1;21(10):1152-1159. doi: 10.1093/ehjci/jez284.
7
Medical and lifestyle management of peripheral arterial disease.
J Vasc Surg. 2018 Nov;68(5):1595-1606. doi: 10.1016/j.jvs.2018.07.027.
10
Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia.
Tech Vasc Interv Radiol. 2016 Jun;19(2):91-5. doi: 10.1053/j.tvir.2016.04.001. Epub 2016 Apr 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验